Ainos(NASDAQ) AIMDW

Market CapN/A

Since IPO (2022)-89%

5 YearN/A

1 Year-82%

1 Month-35%

$0.08

-14.49%

-0.01Today

Ainos last closing stock price
Metric	Price	Date
Last close	USD 0.08	2026-08-20

Ainos stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-19.54%	USD 0.10	2026-08-13
1 month	-35.25%	USD 0.13	2026-07-21
3 month	+38.67%	USD 0.06	2026-05-21
Year to date	-32.36%	USD 0.12	2025-12-31
1 year	-81.92%	USD 0.46	2025-08-20
3 year	-40.57%	USD 0.14	2023-08-21
Since inception	-88.91%	USD 0.75	2022-08-09

Ainos Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$13.60K

Net Income (TTM)

-$14.45M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.36 (Low)

Dividend

$0.00

Beta (Volatility)

-0.36 (Low)

Price

$0.08

Volume

2,153

Open

$0.07

Price

$0.08

Volume

2,153

Open

$0.07

Previous Close

$0.08

Daily Range

$0.06 - $0.08

52-Week Range

$0.05 - $0.27

Estimated Earnings Date

Mar 31, 2023

Dividend

$0.00

Beta (Volatility)

-0.36 (Low)

Price

$0.08

Volume

2,153

Open

$0.07

Previous Close

$0.08

Daily Range

$0.06 - $0.08

52-Week Range

$0.05 - $0.27

Estimated Earnings Date

Mar 31, 2023

AIMDW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ainos

Ainos, Inc. is a healthcare enterprise focused on advancing medical technologies, particularly in point-of-care diagnostics and innovative therapeutic solutions. The company is dedicated to developing products that address various health conditions, including COVID-19 testing and other diagnostic tools.

Products and Services

COVID-19 antigen rapid test kit
Cloud-based test management application
Point-of-care testing for volatile organic compounds

Growth Outlook

Expansion into women's health and pneumonia diagnostics
Development of Synthetic RNA technology platform in Taiwan
Increasing demand for rapid testing solutions post-pandemic

Financial Highlights

Q2 2026 revenue of 152, reflecting ongoing challenges
Net income for Q2 2026 at -4.59 million, indicating operational losses
Cash and cash equivalents decreased to 1.42 million in Q2 2026

Ainos, Inc. operates in a competitive biotechnology sector, focusing on innovative healthcare solutions. The company's product line includes a COVID-19 antigen rapid test kit and a cloud-based test management application, which positions it well in the growing diagnostics market. Despite recent financial challenges, including a net income loss of 4.59 million in Q2 2026, the company is actively pursuing growth opportunities in women's health and pneumonia diagnostics. The development of a Synthetic RNA technology platform in Taiwan further highlights Ainos' commitment to innovation. As the demand for rapid testing solutions continues to rise, Ainos, Inc. remains a company to watch in the evolving healthcare landscape.

AI Generated • Aug 21, 2026

Industry

Technology Hardware, Storage and Peripherals

Sector

Information Technology

Headquarters

Houston, TX 77056, US

AIMDW Financials

Key Financial Metrics (TTM)

Gross Margin

-34987.54%

Operating Margin

-101210.17%

Net Income Margin

-106283.32%

Return on Equity

-217.50%

Return on Capital

-75.37%

Return on Assets

-73.89%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

2.15K

Avg. Volume

1.95K

Financials (TTM)

Gross Profit

-$4.76M

Operating Income

-$13.76M

EBITDA

-$8.96M

Operating Cash Flow

-$4.47M

Capital Expenditure

-$22.93K

Free Cash Flow

-$4.49M

Cash & ST Invst.

$1.42M

Total Debt

$13.81M

Ainos Performance Analysis

Ainos sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-53.5%
Q4	2025-12-31	413.2%
Q1	2026-03-31	-98.6%
Q2	2026-06-30	-5.6%

Ainos sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	35.4%
Q4	2025-12-31	-32.8%
Q1	2026-03-31	51.8%
Q2	2026-06-30	-51.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$152.00

-96.7%

Gross Profit

-$1.19M

+0.4%

Gross Margin

-7803.50%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$4.59M

-12.5%

EBITDA

-$3.21M

-18.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$1.42M

+16.3%

Total Debt

$13.81M

+25.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$308.74K

+92.9%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$13.81M

N/A

Return on Assets

-73.89%

N/A

Return on Invested Capital

-4.19%

N/A

Free Cash Flow

-$1.45M

-8.3%

Operating Cash Flow

-$1.45M

-7.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VRAXVirax Biolabs Group Limited

VRAXVirax Biolabs Group Limited$2.82-1.40%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.00-4.76%

CLABFCore One Labs Inc.

CLABFCore One Labs Inc.$0.00+0.00%

APLIFAppili Therapeutics Inc

APLIFAppili Therapeutics Inc$0.01-22.22%

WINTWindtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.$0.00+200.00%

VAXXVaxxinity, Inc.

VAXXVaxxinity, Inc.$0.00+0.00%

CDTCDT Equity Inc.

CDTCDT Equity Inc.$1.68-0.59%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About AIMDW

What is the current price of Ainos?

Ainos is trading at $0.08 per share.

What is the 52-week range for Ainos?

Over the past 52 weeks, Ainos has traded between $0.05 and $0.27.

How much debt does Ainos have?

Ainos total debt is unavailable.

How much cash does Ainos have on hand?

Ainos does not have cash on hand data available.

What is Ainos’s dividend yield?

Ainos does not currently have a dividend yield.

Ainos(NASDAQ) AIMDW

Ainos Financials at a Glance

AIMDW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ainos

AIMDW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ainos Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AIMDW

What is the current price of Ainos?

What is the 52-week range for Ainos?

How much debt does Ainos have?

How much cash does Ainos have on hand?

What is Ainos’s dividend yield?

Premium Investing Services